Login / Signup

Association of Interleukin-32 and Interleukin-34 with Cardiovascular Disease and Short-Term Mortality in COVID-19.

Christoph C KaufmannAmro AhmedMarie MuthspielIsabella RostockiEdita PogranDavid ZweikerAchim Leo BurgerBernhard JägerGabriele AicherAlexander Oskar SpielFlorian Vafai-TabriziMichael GschwantlerPeter FaschingJohann WojtaKurt Huber
Published in: Journal of clinical medicine (2023)
In our study population of hospitalized patients with COVID-19, IL-32 and IL-34 did not show any associations with CV disease or 28-day mortality in the context of COVID-19. Patients with multiple CV diseases, however, had a significantly increased risk of short-term mortality.
Keyphrases
  • cardiovascular events
  • cardiovascular disease
  • sars cov
  • risk factors
  • type diabetes
  • coronary artery disease
  • cardiovascular risk factors